# FINAL INDEPENDENT AUDIT VERIFICATION REPORT
**Audit Sequence:** Post-Audit Independent Verification (AUDIT-019 through AUDIT-036)  
**Verification Execution Timestamp:** 2026-10-31T11:10:00+05:30  
**Verification Role:** Independent Verification Engineer / Principal Audit Lead  
**Repository Working Directory:** `C:\Users\vigne\OneDrive\Desktop\projects\swing-trading-tool`  
**Production Database File:** `database/swing_trading.db`  
**Verified Production DB SHA-256:** `1A2036FCC72AF59B3633B5C2A077C26DD45756B3360824F36E995E2E805A28A8` (100% Invariant)  

---

## 1. Executive Summary & Verification Purpose

This report documents the rigorous, independent re-verification of the entire master audit sequence (AUDIT-019 through AUDIT-036). Rather than trusting prior summary reports, every key finding was re-derived and calculated directly from the underlying source code, database tables, test execution traces, trade ledger, and daily equity curves.

No trading strategy parameters, scoring weights, stop-loss formulas, target rules, or position-sizing constraints were modified during this verification. The production database was preserved in an immutable, read-only state.

---

## 2. Phase A — Benchmark Mathematics Reconciliation

### A. The Apparent Mathematical Discrepancy
Prior summary tables recorded:
- Full-Horizon Equal-Weight Benchmark: **+2.92%** (`2025-04-01` to `2026-10-23`)
- In-Sample Sub-Period Benchmark: **+0.65%** (`2025-04-01` to `2026-03-31`)
- Out-of-Sample Sub-Period Benchmark: **+1.11%** (`2026-04-01` to `2026-10-23`)
- 6-Month Pilot Period Benchmark: **-7.60%** (`2025-10-01` to `2026-03-31`)

An analyst might ask: *How can the full-horizon benchmark return (+2.92%) exceed the naive compound of the in-sample and out-of-sample sub-period returns (+0.65% and +1.11%)?*

### B. Mathematical Investigation & Root Cause
An independent recalculation directly from all 25,746 records in `daily_prices` across the 52 audited equities revealed the exact causes:

1. **Non-Trading Day on Month-End:**
   In the historical NSE calendar, `2026-03-31` was not a trading session. The final trading session of the In-Sample period occurred on **2026-03-30**.
2. **The Boundary Gap Session (2026-03-30 Close to 2026-04-01 Close):**
   When the Out-of-Sample (OOS) benchmark was calculated using `date >= '2026-04-01'`, the base price $P_0$ for OOS was chosen as the **close of 2026-04-01**. Consequently, the market return of the trading day **2026-04-01** (from the close of `2026-03-30` to the close of `2026-04-01`) was omitted from both the IS and OOS sub-periods.
3. **Magnitude of the Boundary Gap Return:**
   Across all 52 constituent stocks, the average return on `2026-04-01` alone was **+1.4668%** (median: +1.4719%).
4. **Exact Individual Stock Compounding Identity:**
   For every single stock $i \in [1, 52]$, individual compounding is multiplicative and exact to machine floating-point precision ($2.22 \times 10^{-16}$ maximum absolute error):
   $$(1 + R_{full, i}) = (1 + R_{IS, i}) \times (1 + R_{gap, i}) \times (1 + R_{OOS, i})$$
   - Mean $R_{IS}$ (`2025-04-01` to `2026-03-30` close): **+0.6459%** (+0.65%)
   - Mean $R_{gap}$ (`2026-03-30` to `2026-04-01` close): **+1.4668%** (+1.47%)
   - Mean $R_{OOS}$ (`2026-04-01` to `2026-10-23` close): **+1.1075%** (+1.11%)
   - Mean $R_{full}$ (`2025-04-01` to `2026-10-23` close): **+2.9225%** (+2.92%)
   - Mean $R_{OOS\_cont}$ (`2026-03-30` to `2026-10-23` close): **+2.6650%** (+2.67%)
   - Mean $R_{pilot}$ (`2025-10-01` to `2026-03-30` close): **-7.5960%** (-7.60%)

5. **Statistical Correction: Cross-Sectional Mean of Compounded Returns vs. Compound of Means:**
   It is mathematically invalid to assume that subtracting a single covariance term fully reconciles compounded cross-sectional returns. Cross-sectional averaging ($E[\cdot]$) does not commute with multiplicative compounding across time periods:
   $$E\left[\prod_t (1 + R_t)\right] \ne \prod_t (1 + E[R_t])$$
   Expanding the product of the three constituent sub-period return random variables $X = R_{IS}$, $Y = R_{gap}$, $Z = R_{OOS}$:
   $$(1 + X)(1 + Y)(1 + Z) = 1 + X + Y + Z + XY + XZ + YZ + XYZ$$
   Taking expectations across all 52 equities:
   $$E[1 + R_{full}] = 1 + E[X] + E[Y] + E[Z] + E[XY] + E[XZ] + E[YZ] + E[XYZ]$$
   Decomposing using central covariances and the third-order central co-moment $\mu_{1,1,1} = E[(X-\bar{X})(Y-\bar{Y})(Z-\bar{Z})]$:
   $$E[1 + R_{full}] = (1 + E[X])(1 + E[Y])(1 + E[Z]) + \left[\text{Cov}(X, Y)(1 + E[Z]) + \text{Cov}(X, Z)(1 + E[Y]) + \text{Cov}(Y, Z)(1 + E[X]) + \mu_{1,1,1}\right]$$
   Evaluating these terms across the 52 equities:
   - Naive compound of averages: $(1 + 0.006459) \times (1 + 0.014668) \times (1 + 0.011075) - 1 = \mathbf{+3.2532\%}$
   - Actual cross-sectional mean of compounded returns: $\mathbf{+2.9225\%}$
   - Discrepancy: $-0.3307\%$
   - Inter-period covariances and co-moments across the 52 equities:
     - $\text{Cov}(X, Y)(1 + E[Z]) = -0.000026 \times 1.011075 = -0.000026$
     - $\text{Cov}(X, Z)(1 + E[Y]) = -0.003839 \times 1.014668 = -0.003895$ (statistically significant mean-reversion: stocks outperforming in IS underperformed in OOS)
     - $\text{Cov}(Y, Z)(1 + E[X]) = +0.000745 \times 1.006459 = +0.000750$
     - Central 3rd co-moment $\mu_{1,1,1} = -0.000135$
     - Total co-moment sum: $-0.000026 - 0.003895 + 0.000750 - 0.000135 = \mathbf{-0.003306\ (-0.3307\%)}$
     - Reconciled return: $+3.2532\% - 0.3307\% = \mathbf{+2.9225\%}$ (Exact match to 4 decimal places).

### C. Recalculated Strategy vs. Benchmark Spreads
| Period | Strategy Net Return | Equal-Weight Buy-and-Hold | Spread (Active - Passive) | Equal-Weight Daily Rebalanced | Spread (Active - Daily Rebal) |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **Full Horizon (2025-04-01 to 2026-10-23)** | -1.2237% | +2.9225% | **-4.1462%** | +3.74% | **-4.96%** |
| **In-Sample (2025-04-01 to 2026-03-31)** | +0.9590% | +0.6459% | **+0.3131%** | +0.43% | **+0.53%** |
| **Out-of-Sample (2026-04-01 to 2026-10-23)** | -2.1827% | +1.1075% | **-3.2902%** | +3.29% | **-5.47%** |
| **Out-of-Sample (Continuous from 2026-03-30)**| -2.1827% | +2.6650% | **-4.8477%** | — | — |
| **6-Month Pilot (2025-10-01 to 2026-03-31)** | +0.9590% | -7.5960% | **+8.5550%** | -7.27% | **+8.23%** |

---

## 3. Phase B — Transaction-Cost Reconciliation & Portfolio Accounting

### A. SUNPHARMA Transaction-Cost Reconciliation (₹978.32 vs. ₹958.96)
An apparent discrepancy existed between the pilot reports (AUDIT-017 / AUDIT-018 reporting **₹978.32**) and the multi-year backtest reports (AUDIT-025 / AUDIT-026 reporting **₹958.96**).

An independent audit of the trade parameters and cost models reconciled the exact **₹19.36** difference:

| Parameter / Metric | AUDIT-017 / AUDIT-018 Pilot | AUDIT-025 Multi-Year Baseline | Delta / Impact | Mathematical Explanation |
| :--- | :--- | :--- | :--- | :--- |
| **Slippage Assumption** | **5 bps (0.05%)** | **10 bps (0.10%)** | +5 bps | Pilot used 5 bps; multi-year tightened to institutional 10 bps standard. |
| **Raw Entry Price** | ₹1,712.0000 | ₹1,712.0000 | ₹0.0000 | Identical base bar execution price on 2026-03-02 open. |
| **Slipped Entry Price** | ₹1,712.8560 | ₹1,713.7120 | +₹0.8560 | $1712.0 \times 1.0005$ vs. $1712.0 \times 1.0010$. |
| **Raw Target Price** | ₹1,806.6000 | ₹1,806.6000 | ₹0.0000 | Identical base target limit price on 2026-03-09. |
| **Slipped Exit Price** | ₹1,805.6967 | ₹1,804.7934 | -₹0.9033 | $1806.6 \times 0.9995$ vs. $1806.6 \times 0.9990$. |
| **Executed Quantity** | 11 shares | 11 shares | 0 shares | Whole-share sizing: $\lfloor 20,000 / 1713.71 \rfloor = 11$. |
| **Gross P&L** | **₹1,021.2477** | **₹1,001.8954** | **-₹19.3523** | $11 \times (1804.7934 - 1713.7120) - 11 \times (1805.6967 - 1712.8560)$. |
| **Entry Costs** | ₹22.3501 | ₹22.3614 | +₹0.0113 | Statutory turnover charges on slightly higher slipped entry value. |
| **Exit Costs** | ₹20.5823 | ₹20.5719 | -₹0.0104 | Statutory turnover charges on slightly lower slipped exit value. |
| **Total Transaction Costs** | **₹42.9324** | **₹42.9333** | **+₹0.0009** | Zerodha brokerage + STT + GST + stamp duty + exchange turnover + SEBI. |
| **Net P&L** | **₹978.3153 (₹978.32)** | **₹958.9621 (₹958.96)** | **-₹19.3532 (≈ ₹19.36)** | Gross P&L impact (-₹19.3523) minus cost delta (+₹0.0009). |

**Conclusion:** The ₹19.36 change represents no accounting defect. It is the direct mathematical result of updating the slippage parameter from 5 bps in the exploratory pilot to 10 bps in the formal multi-year evaluation.

### B. Independent Trade Summation & Ledger Verification
All 8 trades from the persisted multi-year trade ledger were independently verified down to the nearest paisa:

| Trade ID | Symbol | Entry Date | Slipped Entry | Exit Date | Slipped Exit | Qty | Gross P&L | Entry Costs | Exit Costs | Total Costs | Net P&L | Exit Reason |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| `sim_FULL_10bps_SUNPHARMA_2026-03-02_1` | SUNPHARMA | 2026-03-02 | ₹1,713.7120 | 2026-03-09 | ₹1,804.7934 | 11 | +₹1,001.8954 | ₹22.3614 | ₹20.5719 | ₹42.9333 | +₹958.9621 | TARGET_REACHED |
| `sim_FULL_10bps_WIPRO_2026-04-16_2` | WIPRO | 2026-04-16 | ₹213.1930 | 2026-04-24 | ₹200.2183 | 93 | -₹1,206.6471 | ₹23.5192 | ₹19.2948 | ₹42.8140 | -₹1,249.4611 | STOP_LOSS |
| `sim_FULL_10bps_ETERNAL_2026-04-17_3` | ETERNAL | 2026-04-17 | ₹253.2530 | 2026-05-18 | ₹235.8717 | 78 | -₹1,355.7414 | ₹23.4325 | ₹19.0645 | ₹42.4970 | -₹1,398.2384 | STOP_LOSS |
| `sim_FULL_10bps_MARUTI_2026-07-01_4` | MARUTI | 2026-07-01 | ₹14,165.1510 | 2026-07-14 | ₹13,519.6718 | 1 | -₹645.4792 | ₹16.8032 | ₹14.0094 | ₹30.8126 | -₹676.2918 | STOP_LOSS |
| `sim_FULL_10bps_BAJAJFINSV_2026-07-06_5` | BAJAJFINSV | 2026-07-06 | ₹1,886.9851 | 2026-07-31 | ₹2,030.9670 | 10 | +₹1,439.8190 | ₹22.3840 | ₹21.0454 | ₹43.4294 | +₹1,396.3896 | TARGET_REACHED |
| `sim_FULL_10bps_WIPRO_2026-08-04_6` | WIPRO | 2026-08-04 | ₹189.1890 | 2026-08-18 | ₹179.9067 | 105 | -₹974.6415 | ₹23.5642 | ₹19.5745 | ₹43.1387 | -₹1,017.7802 | STOP_LOSS |
| `sim_FULL_10bps_DRREDDY_2026-09-23_7` | DRREDDY | 2026-09-23 | ₹1,211.2100 | 2026-10-08 | ₹1,170.6435 | 16 | -₹649.0640 | ₹22.9884 | ₹19.4088 | ₹42.3972 | -₹691.4612 | STOP_LOSS |
| `sim_FULL_10bps_INFY_2026-10-06_8` | INFY | 2026-10-06 | ₹1,019.0180 | 2026-10-15 | ₹1,097.9010 | 19 | +₹1,498.7770 | ₹22.9669 | ₹21.6158 | ₹44.5827 | +₹1,454.1943 | TARGET_REACHED |

### C. Cash and Equity Accounting Reconciliation
- **Total Trades:** 8 (3 Wins, 5 Losses, 0 Open)
- **Sum of Gross P&L:** **-₹891.0818** (-₹891.08)
- **Sum of Entry Costs:** ₹178.0198
- **Sum of Exit Costs:** ₹154.5851
- **Sum of Total Costs:** **₹332.6049** (₹332.60)
- **Sum of Net P&L:** **-₹1,223.6867** (-₹1,223.69)
- **Initial Capital:** ₹100,000.00
- **Ending Cash:** ₹100,000.00 - ₹1,223.6867 = **₹98,776.3133** (₹98,776.31)
- **Ending Equity:** **₹98,776.3133** (₹98,776.31)
- **Cost Deduplication Check:** Costs were charged exactly once per entry leg and once per exit leg (16 total cost assessments across 8 closed trades). Zero double-counted fees. Zero omitted trades.

### D. Daily Equity Curve & Drawdown Verification
Tracking the daily mark-to-market equity curve across all 387 sessions verified:
- **Peak Portfolio Equity:** **₹100,958.96** achieved on **2026-03-09** (after closing SUNPHARMA).
- **Trough Portfolio Equity:** **₹96,880.81** reached on **2026-10-08** (after stopping out DRREDDY).
- **Peak-to-Trough Loss:** ₹100,958.96 - ₹96,880.81 = **₹4,078.15**
- **Maximum Drawdown:**
  $$\text{Max Drawdown} = \frac{₹4,078.15}{₹100,958.96} = \mathbf{4.0394\%}$$
  Matches the reported `max_drawdown_pct` of `4.0394%` exactly.

---

## 4. Phase C — Test Isolation & Suite Verification

### A. Inspection of the Five Modified Test Modules
To eliminate the risk of test executions polluting or altering the production database (`database/swing_trading.db`), five test files were inspected:

1. `backend/data_pipeline/test_backtest_result_service.py`:
   - **Isolation Method:** `setUpClass` creates an isolated SQLite database via `tempfile.TemporaryDirectory()`, patches `backtest_result_service.DATABASE_PATH`, and restores the original path in `tearDownClass`.
   - **Assertion Integrity:** 100% of original assertions retained. Zero assertions weakened, skipped, or modified.
2. `backend/data_pipeline/test_week14_integration.py`:
   - **Isolation Method:** `setUpClass` initializes an isolated temporary SQLite database, patches `DATABASE_PATH`, and cleans up in `tearDownClass`.
   - **Assertion Integrity:** Retains all 9 integration steps and end-to-end assertions.
3. `backend/data_pipeline/test_opportunity_score_persistence.py`:
   - **Isolation Method:** Uses `tempfile.TemporaryDirectory()` in `setUpClass` and restores module `DATABASE_PATH` in `tearDownClass`.
   - **Assertion Integrity:** 100% of score persistence and schema assertions retained.
4. `backend/data_pipeline/test_financial_score_persistence.py`:
   - **Isolation Method:** Uses `tempfile.TemporaryDirectory()` in `setUpClass` and restores module `DATABASE_PATH` in `tearDownClass`.
   - **Assertion Integrity:** 100% of financial score assertions retained.
5. `backend/data_pipeline/test_technical_indicator_service.py`:
   - **Isolation Method:** Uses a pytest module-level autouse fixture to create a temporary copy of the database and monkeypatch `DATABASE_PATH` on both `technical_indicator_service` and `config`.
   - **Assertion Integrity:** Retains all indicator calculation and persistence assertions. Completely prevents `sqlite_sequence` mutations on `database/swing_trading.db`.

### B. Preserved Test Execution Outputs
- **Backend Test Suite (810 tests):**
  - Result: **810 passed, 79 subtests passed, 0 failed, 0 errors, 0 skipped** (Execution time: 133.19s).
- **Frontend Test Suite (288 assertions):**
  - Command: `node frontend/src/utils/run_all_tests.js`
  - Result: **288 assertions passed, 0 failed, 0 skipped** (Execution time: 2.1s).
- **Frontend Production Build:**
  - Command: `npm run build`
  - Result: **Vite build completed in 2.46s with zero errors**.

---

## 5. Phase D — Production Database Invariance

- **Database Path:** `database/swing_trading.db`
- **File Size:** 9,068,544 bytes
- **Baseline Checksum:** `1A2036FCC72AF59B3633B5C2A077C26DD45756B3360824F36E995E2E805A28A8`
- **Post-Verification Checksum:** `1A2036FCC72AF59B3633B5C2A077C26DD45756B3360824F36E995E2E805A28A8`
- **Integrity Status:** **100% BYTE-FOR-BYTE INVARIANT**. Zero mutations occurred during any test execution.

---

## 6. Phase E — Fundamental Data Limitations & Lookahead Fallback Disclosure

### Critical Data Limitation Disclosure:
- **100% (260/260) of quarterly results records in `database/swing_trading.db` lack official exchange publication timestamps (`publication_date IS NULL`).**
- **Fallback Operational Rule:** The platform enforces an empirical fallback:
  $$T_{\text{eligible}} = \text{quarter\_period\_end} + 45\text{ days}$$
  derived from SEBI LODR Regulation 33(3)(a), which grants listed Indian companies 45 days following quarter-end to submit un-audited quarterly financial results.
- **Strict Methodological Distinction:**
  The 45-day lag fallback is an **eligibility assumption**, NOT empirical proof of the exact public disclosure date. In actual corporate practice, companies may announce results earlier (e.g., IT majors 15–20 days post-quarter) or experience statutory delays.
- **Lookahead Bias Boundary:**
  While the 45-day fallback successfully eliminates lookahead bias for dates occurring *before* $T_{\text{quarter\_end}} + 45$, **true immunity from lookahead bias cannot be claimed with mathematical certainty until verified exchange announcement timestamps from NSE/BSE corporate filings are ingested into `quarterly_results.publication_date`**.

---

## 7. Phase F — Formal Release Classification Decision

### Track 1: LOCAL ANALYTICS AND RESEARCH BENCH
> ### **STATUS: APPROVED FOR RELEASE**
> **Scope:** Interactive web application, market breadth dashboard, technical screener, sector relative strength rankings, stock detail views, and research simulation workbench.  
> **Verification Basis:**
> - 810 backend unit and integration tests passing.
> - 288 frontend assertions passing.
> - Production Vite build successful (0 errors).
> - 6 of 6 end-to-end user journeys validated.
> - Database integrity verified (`PRAGMA integrity_check` = `ok`, 0 foreign key violations).
> - Production database completely isolated and invariant.
> - Zero hardcoded secrets and zero SQL injection patterns.
> **Scope Constraints:** Evaluates 52 large-cap equities (not full Nifty 100); quarterly financials use 45-day statutory fallback.

### Track 2: PAPER-TRADING READINESS
> ### **STATUS: CONDITIONALLY APPROVED FOR MANUAL / DISCRETIONARY PAPER TRADING**
> **Scope:** Generating daily candidate setups and paper trade journaling.  
> **Mandatory Operating Rules:**
> - The user must manually confirm that the entry price falls strictly within the entry zone.
> - The user must independently verify corporate earnings announcement dates before entering paper trades to prevent trading through earnings.
> - Discretionary review of broader market regime (advancing/declining breadth) is required.

### Track 3: LIVE AUTOMATED TRADING
> ### **STATUS: STRICTLY DISAPPROVED / BLOCKED**
> **Scope:** Unattended, programmatic order execution with real capital.  
> **Non-Negotiable Blockers:**
> 1. **Negative Multi-Year Net Alpha:** Systematic mechanical backtest underperformed passive buy-and-hold by **-4.15%** (-1.22% strategy vs. +2.92% benchmark).
> 2. **Signal Rejection & Trade Starvation:** 99.40% of signals rejected (1,814 of 1,825), generating only 8 executed trades across 1.5 years (~0.44 trades/month). Sample size ($N=8$) is statistically inadequate to infer edge.
> 3. **Missing Publication Timestamps:** 260 of 260 quarterly financial records lack SEBI disclosure timestamps.
> 4. **No Automated Broker API Layer:** Zero production broker execution adapters (Kite Connect, Shoonya, Fyers) currently exist in the codebase.
